| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Cardiovascular Research Institute and 2 Depts of Medicine and Physiology, University of California San Francisco, San Francisco, CA, USA
CORRESPONDENCE: J.A. Nadel, Cardiovascular Research Institute, Box 0130, University of California San Francisco, San Francisco, CA, 94143-0130, USA. Fax: 1 4154762283. E-mail: janadel@itsa.ucsf.edu
Keywords: airway epithelium, mucin production, tyrosine kinase phosphorylation
Received: January 11, 2002
Accepted June 26, 2002
Hypersecretory disease associated with Pseudomonas aeruginosa (PA) infections is characterised by increased goblet cells and increased mucin production. Recently, an epidermal growth factor receptor (EGFR) signalling cascade was shown to be a common pathway through which many stimuli induce mucin MUC5AC expression in airways by differentiation to a goblet cell phenotype. This study looked at whether PA products induce EGFR expression and activation and thus result in mucin MUC5AC production.
Human airway epithelial (NCI–H292) cells were stimulated with PA culture supernatant (Sup). MUC5AC protein production, MUC5AC and EGFR messenger ribonucleic acid (mRNA) expression, and phosphorylated EGFR and phosphorylated p44/42 mitogen-activated protein kinase (MAPK) were all examined using enzyme-linked immunosorbent assay, by in situ hybridisation and by immunoblotting.
PA Sup induced MUC5AC mRNA and subsequent protein expression, EGFR and p44/42 MAPK phosphorylation and EGFR mRNA expression. Induction of MUC5AC mRNA and protein expression and EGFR and p44/42 MAPK phosphorylation were inhibited completely by pretreatment with a selective EGFR tyrosine kinase inhibitor. Pretreatment with a selective inhibitor of MAPK kinase prevented MUC5AC production and p44/42 MAPK phosphorylation but not EGFR phosphorylation.
The authors conclude that PA products induce mucin MUC5AC production in human airway epithelial cells via the expression and activation of epidermal growth factor receptor.
This article has been cited by other articles:
|
|
 |
|
  C. K. Rhee, C. M. Kang, M. B. You, H. K. Yoon, Y. K. Kim, K. H. Kim, H. S. Moon, S. H. Park, and J. S. Song Effect of fudosteine on mucin production Eur. Respir. J., November 1, 2008; 32(5): 1195 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P-R. Burgel and J. A. Nadel Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases Eur. Respir. J., October 1, 2008; 32(4): 1068 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Glasser, A. P. Senft, J. A. Whitsett, M. D. Maxfield, G. F. Ross, T. R. Richardson, D. R. Prows, Y. Xu, and T. R. Korfhagen Macrophage Dysfunction and Susceptibility to Pulmonary Pseudomonas aeruginosa Infection in Surfactant Protein C-Deficient Mice J. Immunol., July 1, 2008; 181(1): 621 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Q. Ding, C. Q. Zheng, and S. S. Bagga Up-regulation of the Mucosal Epidermal Growth Factor Receptor Gene in Chronic Rhinosinusitis and Nasal Polyposis Arch Otolaryngol Head Neck Surg, November 1, 2007; 133(11): 1097 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Kramer, G. H. Deutsch, M. A. Sartor, W. D. Hardie, M. Ikegami, T. R. Korfhagen, and T. D. Le Cras Perinatal increases in TGF-{alpha} disrupt the saccular phase of lung morphogenesis and cause remodeling: microarray analysis Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L314 - L327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Rose and J. A. Voynow Respiratory Tract Mucin Genes and Mucin Glycoproteins in Health and Disease Physiol Rev, January 1, 2006; 86(1): 245 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Xia, J. A. Royall, G. Damera, G. P. Sachdev, and R. D. Cummings Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis Glycobiology, August 1, 2005; 15(8): 747 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Deshmukh, L. M. Case, S. C. Wesselkamper, M. T. Borchers, L. D. Martin, H. G. Shertzer, J. A. Nadel, and G. D. Leikauf Metalloproteinases Mediate Mucin 5AC Expression by Epidermal Growth Factor Receptor Activation Am. J. Respir. Crit. Care Med., February 15, 2005; 171(4): 305 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Mata, B Sarria, A Buenestado, J Cortijo, M Cerda, and E J Morcillo Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells Thorax, February 1, 2005; 60(2): 144 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P-R Burgel and J A Nadel Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium Thorax, November 1, 2004; 59(11): 992 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Kim, S. Y. Lee, S. M. Bak, I. B. Suh, S. Y. Lee, C. Shin, J. J. Shim, K. H. In, K. H. Kang, and S. H. Yoo Effects of matrix metalloproteinase inhibitor on LPS-induced goblet cell metaplasia Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L127 - L133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. X. G. Shao, I. F. Ueki, and J. A. Nadel Tumor necrosis factor {alpha}-converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells PNAS, September 30, 2003; 100(20): 11618 - 11623. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
